Aspergillosis in "nonimmunocompromised" critically ill patients.

Suppr

超能文献

作者信息

Denning David W

出版信息

Am J Respir Crit Care Med. 2004 Sep 15;170(6):580-1. doi: 10.1164/rccm.2407004.

DOI:10.1164/rccm.2407004

PMID:15355869

Abstract

摘要

相似文献

Aspergillosis in "nonimmunocompromised" critically ill patients.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):580-1. doi: 10.1164/rccm.2407004.

Aspergillus infections in the critically ill.

Proc Am Thorac Soc. 2010 May;7(3):204-9. doi: 10.1513/pats.200906-050AL.

How to manage aspergillosis in non-neutropenic intensive care unit patients.

Crit Care. 2014 Jul 25;18(4):458. doi: 10.1186/s13054-014-0458-4.

Aspergillosis in the 'nonimmunocompromised' host.

Immunol Invest. 2011;40(7-8):751-66. doi: 10.3109/08820139.2011.614307.

[Chronic necrotizing pulmonary aspergillosis in an immunocompromised patient].

Orv Hetil. 2004 Aug 29;145(35):1811-5.

Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.

Semin Respir Crit Care Med. 2019 Aug;40(4):540-547. doi: 10.1055/s-0039-1696968. Epub 2019 Oct 4.

[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].

Enferm Infecc Microbiol Clin. 2012 Apr;30(4):219-20. doi: 10.1016/j.eimc.2011.11.002. Epub 2012 Feb 24.

[Probable invasive pulmonary aspergillosis and inhaled steroids treatment].

Enferm Infecc Microbiol Clin. 2002 Mar;20(3):131-2. doi: 10.1016/s0213-005x(02)72765-1.

Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit.

Int J Hyg Environ Health. 2002 Feb;204(5-6):347-51. doi: 10.1078/1438-4639-00106.

Invasive aspergillosis in 2002: an update.

Eur J Clin Microbiol Infect Dis. 2002 Mar;21(3):161-72. doi: 10.1007/s10096-002-0699-z. Epub 2002 Mar 22.

引用本文的文献

Follow-up of Surgical and Nonsurgical Patients With Pulmonary Aspergillosis: A Real-World Study.

Infect Drug Resist. 2025 Feb 21;18:1059-1070. doi: 10.2147/IDR.S496765. eCollection 2025.

Outbreak in an Intensive Care Unit: Source Analysis with Whole Genome Sequencing and Short Tandem Repeats.

J Fungi (Basel). 2024 Jan 6;10(1):51. doi: 10.3390/jof10010051.

Identification and management of invasive mycoses in internal medicine: a road-map for physicians.

Intern Emerg Med. 2014 Aug;9(5):501-11. doi: 10.1007/s11739-014-1077-4. Epub 2014 May 29.

Infections in chronic lung diseases.

Infect Dis Clin North Am. 2007 Sep;21(3):673-95, viii. doi: 10.1016/j.idc.2007.06.006.

In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis.

J Clin Microbiol. 2006 May;44(5):1711-8. doi: 10.1128/JCM.44.5.1711-1718.2006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Aspergillosis in "nonimmunocompromised" critically ill patients.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):580-1. doi: 10.1164/rccm.2407004.

Aspergillus infections in the critically ill.

Proc Am Thorac Soc. 2010 May;7(3):204-9. doi: 10.1513/pats.200906-050AL.

How to manage aspergillosis in non-neutropenic intensive care unit patients.

Crit Care. 2014 Jul 25;18(4):458. doi: 10.1186/s13054-014-0458-4.

Aspergillosis in the 'nonimmunocompromised' host.

Immunol Invest. 2011;40(7-8):751-66. doi: 10.3109/08820139.2011.614307.

[Chronic necrotizing pulmonary aspergillosis in an immunocompromised patient].

Orv Hetil. 2004 Aug 29;145(35):1811-5.

Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.

Semin Respir Crit Care Med. 2019 Aug;40(4):540-547. doi: 10.1055/s-0039-1696968. Epub 2019 Oct 4.

[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].

Enferm Infecc Microbiol Clin. 2012 Apr;30(4):219-20. doi: 10.1016/j.eimc.2011.11.002. Epub 2012 Feb 24.

[Probable invasive pulmonary aspergillosis and inhaled steroids treatment].

Enferm Infecc Microbiol Clin. 2002 Mar;20(3):131-2. doi: 10.1016/s0213-005x(02)72765-1.

Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit.

Int J Hyg Environ Health. 2002 Feb;204(5-6):347-51. doi: 10.1078/1438-4639-00106.

Invasive aspergillosis in 2002: an update.

Eur J Clin Microbiol Infect Dis. 2002 Mar;21(3):161-72. doi: 10.1007/s10096-002-0699-z. Epub 2002 Mar 22.

引用本文的文献

Follow-up of Surgical and Nonsurgical Patients With Pulmonary Aspergillosis: A Real-World Study.

Infect Drug Resist. 2025 Feb 21;18:1059-1070. doi: 10.2147/IDR.S496765. eCollection 2025.

Outbreak in an Intensive Care Unit: Source Analysis with Whole Genome Sequencing and Short Tandem Repeats.

J Fungi (Basel). 2024 Jan 6;10(1):51. doi: 10.3390/jof10010051.

Identification and management of invasive mycoses in internal medicine: a road-map for physicians.

Intern Emerg Med. 2014 Aug;9(5):501-11. doi: 10.1007/s11739-014-1077-4. Epub 2014 May 29.

Infections in chronic lung diseases.

Infect Dis Clin North Am. 2007 Sep;21(3):673-95, viii. doi: 10.1016/j.idc.2007.06.006.

In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis.

J Clin Microbiol. 2006 May;44(5):1711-8. doi: 10.1128/JCM.44.5.1711-1718.2006.